Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.
about
Minocycline for acne vulgaris: efficacy and safetyHydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing associationThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsInfluence of environmental factors on the onset and course of inflammatory bowel diseaseSpironolactone for the treatment of acne in women, a retrospective study of 110 patients.Antibiotic exposure and IBD development among children: a population-based cohort studyImportant controversies associated with isotretinoin therapy for acne.Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative ColitisInflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.Phenome-driven disease genetics prediction toward drug discovery.DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria.Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in WomenThe Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis.Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells?Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.Drug-induced inflammatory bowel disease and IBD-like conditions.Drug-induced gastrointestinal disorders.Adverse effects of acne medications: recognition and management.Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review.Rosacea and gastrointestinal disorders: a population-based cohort study.Antibiotic use and the risk of Crohn's diseaseAssociation of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study.Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad.Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study.Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.69th annual meeting of the American Academy of Dermatology: New Orleans, Louisiana, USA, 4-8 February 2011.A review of diagnosis and treatment of acne in adult female patients.
P2860
Q24201716-EBF1E482-DDB1-498D-AFD8-9EF33284BC23Q26745455-22011BDE-EFCD-4096-B712-615BD91F97CFQ26745700-A85688E7-16DD-45F9-83FF-42241D03E795Q26774548-0C5689B0-6288-437C-A365-4945DAC84081Q33715142-CF705F56-CEBE-4C1D-BE24-C33841EF2B5AQ33819564-E9535FA2-DCC3-4AA3-9E75-0EC1E15D14FFQ34337328-C22500BC-6FA8-46FF-B8FB-5AC13118D355Q35657007-F10261F3-9091-42AA-BE1E-85E1C034E128Q35807983-1809A2D6-6862-4090-834A-A3602DDA5A15Q35975061-C41961AE-CFB0-4B85-A501-A4766C5460E6Q36010298-A65EEE3C-CAAC-451A-8476-BA833C9AC537Q36242017-326B09E8-2DD6-4895-A258-1FB295BB2379Q36479945-DC8914D0-59F1-4ACE-A0C1-8FDE604DCBC3Q36864731-D3A2AEE1-2381-4C08-BDD9-FE7BA0590274Q37056825-7E8803C3-311C-40C0-A993-A3ADEEA6A584Q37419922-DEE6D736-3EF0-4B35-B87E-19E6A4500936Q37723798-C192C71B-F92C-4AF8-99C1-13DB6EC52C71Q38008983-300B4863-E4CD-4B91-BDEC-1AEB64DE6EBDQ38221321-C5B076E4-2BC6-44AB-94C9-08D9A71C9E2EQ38432225-44BA9ED2-A808-41E1-B1EA-F6D1467A889FQ39159410-15F5D1C7-05DA-4027-9663-3A2FBBA1D454Q39512887-FB2F1B7B-3ADE-4AA9-95BC-EFED088A2A3BQ42543752-88C80F7F-63D4-4D9C-8426-F2D8CC723D5EQ42637837-0B72A69E-910A-47C3-9237-16E03183B335Q45155534-E8723F5B-F7E1-4E41-9082-A25E1DED3B33Q46591206-4BF75414-12B4-4C36-8DA0-0EF4F90DEBE8Q47800875-58C9A92D-ACD0-4B00-B707-6380AE16649FQ47815836-2C2AC7BC-CDBB-4382-BC04-3C99D0C3F99BQ51161842-DBE54C91-8C51-4DF8-A7AF-8F05F4E8370EQ55333511-E2F9EC0D-539B-4B4B-A441-6BD7EF406CBD
P2860
Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potential association between ...... nd inflammatory bowel disease.
@ast
Potential association between ...... nd inflammatory bowel disease.
@en
Potential association between ...... nd inflammatory bowel disease.
@nl
type
label
Potential association between ...... nd inflammatory bowel disease.
@ast
Potential association between ...... nd inflammatory bowel disease.
@en
Potential association between ...... nd inflammatory bowel disease.
@nl
prefLabel
Potential association between ...... nd inflammatory bowel disease.
@ast
Potential association between ...... nd inflammatory bowel disease.
@en
Potential association between ...... nd inflammatory bowel disease.
@nl
P2093
P2860
P356
P1476
Potential association between ...... nd inflammatory bowel disease.
@en
P2093
David J Margolis
James D Lewis
Matthew Fanelli
Ole Hoffstad
P2860
P304
P356
10.1038/AJG.2010.303
P407
P577
2010-08-10T00:00:00Z